Literature DB >> 15772847

[Olfactory dysfunction due to nasal sinus disease. Causes, consequences, epidemiology, and therapy].

T Hummel1, K B Hüttenbrink.   

Abstract

Olfaction not only contributes to our quality of life but, among other functions, it is also necessary for identifying potential dangers, e.g., fire or spoilt food. In general the value of olfaction is only recognized when the sense of smell is impaired or lost. Olfactory dysfunction is diagnosed according to its cause (e.g., sinonasal, post-traumatic, post-upper respiratory tract infection, neurodegenerative, and idiopathic). At present little is known about prognostic factors for predicting resolution of olfactory loss on an individual basis. In cases of impaired olfaction due to sinonasal disease, both conservative and operative treatments have been established. Corticoids are used both topically and systemically. In cases of severe mechanical obstructions or advanced stages of nasal polyposis, FESS (functional endoscopic sinus surgery) seems to be the state of the art.

Entities:  

Mesh:

Year:  2005        PMID: 15772847     DOI: 10.1007/s00106-005-1233-2

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  38 in total

1.  [Screening of olfaction with smell diskettes].

Authors:  D Simmen; H R Briner; K Hess
Journal:  Laryngorhinootologie       Date:  1999-03       Impact factor: 1.057

2.  Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis.

Authors:  B A Stuck; A Blum; A E Hagner; T Hummel; L Klimek; K Hörmann
Journal:  Allergy       Date:  2003-11       Impact factor: 13.146

3.  Clinical validation of a new olfactory test.

Authors:  B Kremer; L Klimek; R Mösges
Journal:  Eur Arch Otorhinolaryngol       Date:  1998       Impact factor: 2.503

4.  [Gustatory olfactory function test with the Güttich technique: an evaluation of the clinical value].

Authors:  T Hummel; K Rosenheim; M Knecht; S Heilmann; D Mürbe; K B Hüttenbrink
Journal:  Laryngorhinootologie       Date:  1999-11       Impact factor: 1.057

5.  The loss of sense of smell in nasal allergy.

Authors:  B T Fein; P B Kamin; N N Fein
Journal:  Ann Allergy       Date:  1966-06

6.  Anosmia and chronic sinus disease.

Authors:  L L Downey; J B Jacobs; R A Lebowitz
Journal:  Otolaryngol Head Neck Surg       Date:  1996-07       Impact factor: 3.497

7.  Impact of olfactory impairment on quality of life and disability.

Authors:  T Miwa; M Furukawa; T Tsukatani; R M Costanzo; L J DiNardo; E R Reiter
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-05

8.  Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds.

Authors:  G Kobal; L Klimek; M Wolfensberger; H Gudziol; A Temmel; C M Owen; H Seeber; E Pauli; T Hummel
Journal:  Eur Arch Otorhinolaryngol       Date:  2000       Impact factor: 2.503

9.  Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis.

Authors:  A Toft; J A Wihl; J Toxman; N Mygind
Journal:  Clin Allergy       Date:  1982-07

10.  Results of oral steroid treatment in nasal polyposis.

Authors:  C van Camp; P A Clement
Journal:  Rhinology       Date:  1994-03       Impact factor: 3.681

View more
  3 in total

1.  Hidden consequences of olfactory dysfunction: a patient report series.

Authors:  Andreas Keller; Dolores Malaspina
Journal:  BMC Ear Nose Throat Disord       Date:  2013-07-23

2.  Olfactory function following open rhinoplasty: A 6-month follow-up study.

Authors:  Hashem Shemshadi; Mojtaba Azimian; Mohammad Ali Onsori; Mahdi Azizabadi Farahani
Journal:  BMC Ear Nose Throat Disord       Date:  2008-10-03

3.  Acupuncture is associated with a positive effect on odour discrimination in patients with postinfectious smell loss-a controlled prospective study.

Authors:  Tanja Drews; Thomas Hummel; Bettina Rochlitzer; Bettina Hauswald; Antje Hähner
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-25       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.